Impax Asset Management Group PLC Sarepta Therapeutics, Inc. Transaction History

Impax Asset Management Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $186,399 - $239,801	-2,412 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $159,119 - $223,061	2,412 New	2,412 $223,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $163,790 - $383,009	-2,267 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $284,644 - $405,203	2,267 New	2,267 $387,000

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.2B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.